Gatifloxacin

Back to search

Molecule Structure

Scientific Name

Gatifloxacin

Description of the Drug

Gatifloxacin is a fourth generation fluoroquinolone used to treat a wide variety of infections in the body.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01044

Brand Name(s)

Gatifloxacin, Tequin, Zymar, Zymaxid

Company Owner(s)

Apotex Inc, Bristol Myers Squibb, Sandoz Inc, Allergan, Bristol Myers Squibb Co Pharmaceutical Research Institute, Allergan Inc, Akorn Operating Co Llc, Torrent Pharmaceuticals Ltd, Lupin Ltd, Rising Pharma Holdings Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Topoisomerase IV PROTEIN COMPLEX INHIBITOR CHEMBL2363033
DNA gyrase PROTEIN COMPLEX INHIBITOR CHEMBL2311225

Unichem Links

SureChEMBL SCHEMBL22591
PharmGKB PA449738
Human Metabolome Database HMDB0015178
DrugBank DB01044
PubChem: Thomson Pharma 14755600
PubChem 5379 4872633
Mcule MCULE-4557972261
NMRShiftDB 80004384
LINCS LSM-5139
Nikkaji J523.172H
BindingDB 50117914
EPA CompTox Dashboard DTXSID5045704
DrugCentral 1280
Brenda 253090
ChemicalBook CB2726045
Guide to Pharmacology 10816
rxnorm GATIFLOXACIN ZYMAR GATIFLOXACIN ANHYDROUS ZYMAXID
PubChem: Drugs of the Future 12014137
KEGG Ligand C07661
ChEBI 5280